Hongda High-Tech issued a profit warning, with a net profit of 22 million to 28 million yuan for the year 2024, a decrease of 65.96% to 73.25%
Hongda High-Tech released its performance forecast for 2024, expecting a net profit of 22 million to 28 million yuan, a year-on-year decrease of 65.96% to 73.25%. Although the fabric weaving and medical device businesses are operating normally, with an increase in operating revenue and net profit from main business, the net profit from the medical device industry has decreased. The company is increasing its investment in Zhejiang Weierde to promote product development and market expansion
According to the Zhitong Finance APP, Hongda High-Tech (002144.SZ) released its performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company to be between 22 million and 28 million yuan, a year-on-year decrease of 65.96% to 73.25%.
During the reporting period, the company's dual main businesses of fabric weaving and medical devices operated normally, with both operating revenue and net profit from main businesses showing growth. Among them, the mother company's production and sales of automotive interior fabrics and functional apparel fabrics grew steadily, with the mother company's operating revenue increasing by approximately 20% year-on-year, and the gross profit margin remaining stable. At the same time, the company increased its investment in product development and market expansion for its subsidiary Zhejiang Weierde Intelligent Medical Technology Co., Ltd., which reduced the net profit of the company's medical device industry. During the reporting period, Zhejiang Weierde obtained three medical device registration certificates and successfully developed intelligent massage robots and the "AI Huiying" series of color ultrasound diagnostic equipment, and is gradually establishing a stable sales team and distribution network
